Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Moxifloxacin impurity 4 (8-Ethoxymoxifloxacin) is a notable impurity associated with the antibiotic Moxifloxacin. This compound is utilized primarily for the analysis of drug purity and quality control in pharmaceutical research. It serves as a standard reference material for assessing the presence of impurities in formulations, ensuring compliance with regulatory standards. Researchers can employ this impurity in method development or validation studies to enhance the reliability of analytical results in antibiotic formulation assessments. -
Drug Impurity
Ranolazine impurity 1, also known as Ranolazine bis(N-oxide), is a chemical impurity associated with the antianginal agent Ranolazine. This compound serves as a valuable reference standard for analytical and quality control purposes in pharmacological research. Its characterization is essential for assessing the purity and stability of Ranolazine formulations in drug development and regulatory compliance. -
Drug Impurity
Afatinib impurity 35 is a chemical impurity associated with the kinase inhibitor Afatinib, which targets epidermal growth factor receptor (EGFR) signaling pathways. This impurity can be utilized in the characterization and quality control of Afatinib formulations to ensure regulatory compliance and validate analytical methods. It serves as an important reference standard in pharmaceutical development and research involving EGFR-targeted therapies. -
Drug Intermediate
3,2'-Dihydroxyflavone is a flavonol compound primarily utilized as a drug intermediate in the synthesis of tetracyclic compounds. It exhibits notable biological activity, making it a valuable reagent in pharmaceutical research. Its structural characteristics allow for further modifications, contributing to the development of novel therapeutic agents. -
Drug Impurity
Edaravone impurity 2 is a known impurity associated with Edaravone, a neuroprotective agent. This compound can be employed in the analysis of drug purity and stability in pharmaceutical research. Its characterization is essential for ensuring the quality and safety of Edaravone formulations in drug development and regulatory compliance. -
Drug Impurity
Itraconazole impurity 3 is a chemical impurity associated with the antifungal agent Itraconazole. This compound is crucial for analytical research and characterization of drug formulations. Its assessment can support regulatory compliance and quality control in pharmaceutical development. Itraconazole impurity 3 aids in understanding the stability and integrity of Itraconazole-related products. -
Drug Impurity
Sertraline impurity 8 is a known impurity of the antidepressant sertraline, acting primarily as a metabolic byproduct. This compound is important for analytical development and quality control in pharmaceutical research related to sertraline synthesis and formulation. Its characterization helps ensure the purity and safety of pharmaceutical products containing sertraline. -
Drug Impurity
Febuxostat impurity 15 is a chemical reagent classified as a drug impurity of febuxostat. It serves as an important marker for quality control and analytical studies during the synthesis and evaluation of febuxostat, a xanthine oxidase inhibitor. This impurity is crucial for ensuring the purity and safety of pharmaceutical formulations containing febuxostat, aiding researchers in understanding its metabolic pathways and potential effects. -
Drug Impurity
Thioridazine impurity 4, also known as Sulforidazine, is a structural impurity of Thioridazine. This compound may be present during the synthesis of Thioridazine and is relevant for analytical and quality control processes in pharmaceutical development. Research applications include the identification and quantification of impurities in drug formulations, providing essential data for ensuring drug safety and efficacy. -
Drug Impurity
Citalopram impurity 6 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This compound is utilized primarily in quality control and analytical studies to assess the purity of pharmaceutical formulations. Its characterization plays an important role in ensuring the safety and efficacy of Citalopram as well as in the development of analytical methods for pharmaceutical research. -
Drug Impurity
Imatinib impurity 2 is a chemical impurity associated with Imatinib, specifically relevant in pharmaceutical quality control. It serves as a vital reference standard for assessing the purity of Imatinib in bulk drug substances and formulations. This impurity is important for studies focusing on drug stability and toxicological evaluations, ensuring the safety and efficacy of Imatinib-related therapeutic applications. -
Drug Impurity
Quetiapine impurity 21 is a known impurity of the antipsychotic drug Quetiapine, primarily affecting the compound's purity assessment. This impurity can be utilized in the analysis of pharmaceutical formulations to ensure compliance with regulatory standards. Its presence can impact the pharmacological profile of Quetiapine, making it relevant in studies focused on drug development and quality control. -
Drug Impurity
Etoposide impurity 1 is a recognized impurity associated with the chemotherapeutic agent Etoposide. This compound serves as a valuable reference standard in the analysis of drug formulations and quality control processes. Its presence can impact the efficacy and safety profiles of Etoposide, making it significant for research into drug development and pharmacokinetics. -
Adrenaline Impurity
Methoxy adrenaline hydrochloride is a synthetic analog of adrenaline, serving as a known impurity in adrenaline formulations. Its presence is critical for quality control in pharmaceutical research, allowing for the assessment of purity and stability in adrenaline products. This compound can also be utilized in various biological studies to investigate adrenergic receptor interactions and signaling pathways. -
Drug Impurity
Canagliflozin impurity 5 is a known impurity of the antidiabetic agent Canagliflozin, which primarily functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This impurity may be useful in drug development studies and quality control processes to evaluate the purity of Canagliflozin formulations. It supports a range of research applications related to pharmacological assessments and safety profiling in the context of diabetes treatment. -
Drug Impurity
Meloxicam impurity 2 is a chemical impurity associated with Meloxicam, a non-steroidal anti-inflammatory drug (NSAID). This impurity is essential for comprehensive drug quality assessments and stability studies. Researchers can utilize Meloxicam impurity 2 to ensure the purity and efficacy of formulations in pharmaceutical development, facilitating compliance with regulatory standards. -
Drug Impurity
Metoprolol Impurity 13 is a chemical impurity associated with Metoprolol, a selective beta-1 adrenergic receptor antagonist. This impurity can be utilized for analytical purposes in drug development, including stability studies and quality control assessments. Researchers can employ this compound to ensure the purity and compliance of Metoprolol formulations in pharmaceutical applications. -
Drug Impurity
Metronidazole impurity 1 is a secondary compound associated with Metronidazole, serving as a drug impurity. This substance is often analyzed in quality control processes to ensure the purity of Metronidazole formulations. It is relevant in research applications focused on pharmacokinetics and safety assessment of drug products. -
Drug Impurity
Rivastigmine impurity 4 is a chemical impurity associated with Rivastigmine, a reversible inhibitor of acetylcholinesterase. This impurity is relevant in the quality control and analytical evaluation of Rivastigmine formulations. Research applications include pharmacokinetic studies and the assessment of drug stability. -
Drug Impurity
Hydrocortisone impurity 12 is a known impurity of hydrocortisone. This compound is primarily utilized in pharmaceutical development and analytical chemistry to assess the purity of hydrocortisone formulations. Its presence can impact the overall efficacy and safety profiles of steroid-based treatments, making it essential for quality control in drug manufacturing and regulatory compliance studies. -
Drug Impurity
Aripiprazole impurity 5 is a characterized impurity associated with the antipsychotic agent Aripiprazole. This compound is crucial for quality control and analysis in pharmaceutical development, facilitating the detection and quantification of impurities during drug synthesis. Its study can enhance understanding of Aripiprazole's stability and formulation, contributing to the overall safety and efficacy of antipsychotic therapies. -
Drug Impurity
Rebamipide methyl ester is a known impurity of Rebamipide, primarily utilized in chemical research. This compound serves as a reference standard for quality control and analytical purposes in the development and analysis of pharmaceuticals. Its presence can affect the potency and efficacy of formulations, making it essential for researchers studying the pharmacological properties of Rebamipide. -
Drug Impurity
Quetiapine impurity 12, also known as 7-Hydroxy quetiapine S-oxide, is identified as a drug impurity of quetiapine. This compound is important for pharmacokinetic studies and quality control assessments of quetiapine formulations. Its presence in pharmaceutical preparations requires monitoring to ensure product safety and efficacy in clinical applications. -
Drug Impurity
Dexamethasone impurity 1 is a known impurity of the corticosteroid Dexamethasone, primarily involved in pharmaceutical quality control. This compound is utilized in research to assess the purity of Dexamethasone formulations and to understand the implications of impurities on drug efficacy and safety. It serves as an important analytical standard for ensuring the integrity of corticosteroid products. -
Drug Impurity
Nicotinamide impurity 4 is a recognized impurity of Nicotinamide, primarily serving as a reference standard in drug development. It is important for assessing the purity and quality of Nicotinamide formulations. Researchers often utilize this impurity to ensure compliance with regulatory requirements during the analytical evaluation and characterization of pharmaceutical compounds. -
Drug Impurity
Azilsartan impurity 18 is a by-product associated with the synthesis of Azilsartan, an angiotensin II receptor antagonist. This impurity can be utilized in analytical studies to assess the purity and quality of pharmaceutical formulations containing Azilsartan. It plays a critical role in ensuring compliance with regulatory standards and understanding the implications of impurities in drug efficacy and safety. -
Drug Impurity
O-Methyl Meloxicam is a structural impurity of Meloxicam, primarily identified as impurity 4. It serves as a useful reference standard for analytical chemistry, particularly in the assessment of drug quality and purity. This compound is relevant in pharmacokinetic studies and stability testing within pharmaceutical research, aiding in the comprehensive characterization of Meloxicam formulations. -
Drug Impurity
Ketoprofen impurity 10 is a known impurity associated with the nonsteroidal anti-inflammatory drug, Ketoprofen. This compound is used primarily in pharmaceutical research to assess the purity and quality of Ketoprofen formulations. Its presence may affect the drug's efficacy and safety profile, making it essential for method development and validation in drug analysis. -
Drug Impurity
Rosuvastatin impurity 36 is a specific impurity related to the statin drug Rosuvastatin, which targets HMG-CoA reductase. This compound is critical for characterizing the purity and quality of Rosuvastatin formulations in pharmaceutical research. It is utilized in studies focusing on drug formulation, stability testing, and impurity profiling to ensure compliance with regulatory standards. -
Drug Intermediate Control
4-(2-Acetoxyacetyl)phenyl acetate is a synthetic intermediate primarily utilized in the synthesis of phenethylamine metabolites. This compound serves as a valuable tool in drug development and medicinal chemistry research, facilitating the exploration and production of various therapeutic agents. Its role in synthetic routes enhances the efficiency of creating diverse chemical structures for biological applications. -
Drug Impurity
Acetazolamide impurity 4 is a known impurity associated with Acetazolamide, a carbonic anhydrase inhibitor. This compound serves as a critical reference standard for analytical applications in drug development and quality control. Its characterization is essential for ensuring the purity and efficacy of Acetazolamide formulations in pharmaceutical research. -
Drug Impurity
Thioridazine impurity 2 is a chemical impurity associated with the antipsychotic agent Thioridazine. It may serve as a valuable reference standard for analytical testing and quality control in pharmaceutical research. This compound is pertinent for studies focused on drug purity and the characterization of Thioridazine formulations. -
Drug Impurity
Apixaban impurity 3 is a chemical impurity associated with Apixaban, an anticoagulant that inhibits Factor Xa, playing a critical role in the coagulation cascade. This impurity is important for quality control and analytical studies in pharmaceutical research to ensure the safety and efficacy of Apixaban formulations. Researchers may utilize this compound for stability testing and impurity profiling as part of regulatory compliance in drug development. -
Drug Impurity
Glipizide impurity 9 is a known impurity associated with Glipizide, an antihyperglycemic agent used to manage diabetes mellitus. This compound is relevant for researchers focusing on the pharmacokinetics and safety profiles of Glipizide formulations. Its study is crucial for ensuring the quality and efficacy of pharmaceutical products in diabetes treatment. -
Drug Impurity
Trazodone impurity 13 is a known impurity associated with the antidepressant Trazodone. This compound serves as a crucial reference standard for assessing the purity and quality of Trazodone formulations. Its identification and quantification are essential in pharmaceutical development and quality control processes, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Mycophenolate impurity 1, also known as O-Desmethyl mycophenolate mofetil, serves as a drug impurity associated with Mycophenolate. This compound is essential for quality control and analytical applications in pharmaceutical development, particularly in assessing the purity of Mycophenolate formulations. Its presence can influence the pharmacokinetics and efficacy of Mycophenolate, making it a relevant focus for researchers investigating drug formulation and safety. -
Drug Intermediate
N1,N4-Di-P-tolylbenzene-1,4-diamine is an important chemical intermediate widely utilized in organic synthesis. This compound serves as a catalyst, enhancing the efficiency of various reactions and promoting the formation of targeted molecular structures. Its unique properties make it valuable for research applications in drug discovery and development, as it aids in the synthesis of complex pharmaceutical compounds. -
Drug Impurity
Carvedilol impurity 2, or 6,7,8,9-Tetrahydro carvedilol, functions as a drug impurity associated with carvedilol synthesis. This compound may be utilized in pharmacological studies to assess the purity of carvedilol and investigate its pharmacokinetic properties. Understanding the presence and effects of this impurity can aid in refining drug formulation and ensuring optimal therapeutic efficacy. -
Drug Impurity
Ketoprofen impurity 11 is a chemical impurity associated with the analgesic and anti-inflammatory agent Ketoprofen. This impurity can play a critical role in pharmacological research, particularly in the development and quality control of pharmaceutical formulations. Its characterization and analysis are essential for ensuring the safety and effectiveness of Ketoprofen-derived products. -
Drug Impurity
Fenirofibrate impurity 3 is a structural byproduct of Fenirofibrate, a medication primarily used to treat lipid disorders. This impurity is critical for quality control and analytical studies in pharmaceutical research, ensuring the safety and efficacy of the drug. Additionally, it serves as a reference material in the characterization and analysis of Fenirofibrate formulations. -
Drug Impurity
Salbutamol impurity 2 hydrochloride is a known impurity of Salbutamol hydrochloride. This compound serves as an important reference standard for the identification and quantification of impurities in pharmaceutical formulations. It is primarily used in analytical chemistry and quality control processes within the pharmaceutical industry to ensure the safety and efficacy of Salbutamol-containing products. -
Drug Impurity
Duloxetine impurity 13 is a significant impurity associated with the pharmaceutical compound Duloxetine. This reagent is crucial for analytical and quality control studies to assess the purity of Duloxetine formulations. It is primarily utilized in the characterization and quantification of drug impurities within pharmaceutical research and development. -
Drug Impurity
Dabigatran impurity 10 is a chemical impurity associated with the anticoagulant drug Dabigatran. This substance is crucial for analytical and quality control studies in pharmaceutical research, particularly in the context of drug formulation and safety assessment. It plays a significant role in understanding the purity profiles and potential impacts of impurities in pharmacological applications. -
Drug Impurity
Famotidine impurity 7, also known as Famotidine disulfide, is a chemical impurity associated with Famotidine. It serves as a valuable reference standard for analytical characterization and quality control in pharmaceutical research. Its presence may affect the safety and efficacy profiles of formulations containing Famotidine, making it relevant for studies focused on drug metabolism and impurities. -
Drug Impurity
Tenofovir impurity 14 is a chemical impurity associated with the antiviral agent Tenofovir. This impurity can be utilized in the quality control and analytical testing of Tenofovir formulations. Its presence in drug preparations is critical for evaluating the purity and safety of pharmaceutical products, making it relevant for analytical chemistry and pharmaceutical research. -
Drug Impurity
Tramadol impurity 3 is a chemical impurity associated with Tramadol. It serves as an important reference standard for quality control and analytical purposes in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of Tramadol formulations, ensuring compliance with regulatory standards. Analysis of such impurities helps in understanding potential effects on drug safety and efficacy. -
Drug Impurity
Ropinirole impurity 5 is a chemical impurity associated with Ropinirole, a dopamine agonist primarily targeting the D2 and D3 dopamine receptors. This impurity is important for analytical and quality control purposes in pharmaceutical research and development. Its identification and quantification are crucial for ensuring the purity and safety of Ropinirole formulations. -
Drug Impurity
Cinacalcet impurity 1 hydrochloride is a known impurity of the calcimimetic agent Cinacalcet, which primarily targets the calcium-sensing receptor. This compound is important for quality control and analytical studies in the development and regulatory assessment of Cinacalcet. It can also be used in research focused on drug metabolism and pharmacokinetics associated with calcimimetic therapies. -
Drug Impurity
Tacrolimus impurity 8, also known as delta23-FK-506, is a characterized impurity of the immunosuppressive agent Tacrolimus. This compound is primarily utilized for the assessment of drug purity and quality control in pharmaceutical development. Its presence can serve as a critical reference for analytical methods aimed at ensuring the safety and efficacy of Tacrolimus formulations. -
Drug Intermediate Control
5-Dibromomethyl anastrozole is a synthetic intermediate utilized in the production of the aromatase inhibitor Anastrozole (CYP19A1). This compound plays a critical role in the synthesis pathway, aiding in the development of therapies targeting estrogen receptor-positive breast cancer. Its biological activity contributes to the effective modulation of estrogen levels for research into related oncological applications.
